Cargando…

miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5

Lung adenocarcinoma (LUAD) has been considered as the most common cause of cancer-associated mortality. Radiotherapy resistance is one of the main reasons for LUAD treatment failure. The microRNA (miR)-101-3p has been previously reported to function as a tumor suppressor in several types of cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xin, Sun, Yanfei, Liu, Shiying, Mu, Yanchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905603/ https://www.ncbi.nlm.nih.gov/pubmed/33732358 http://dx.doi.org/10.3892/ol.2021.12543

Ejemplares similares

miR-101-3p sensitizes non-small cell lung cancer cells to irradiation
por: Li, Zhonghui, et al.
Publicado: (2020)

miR‐126‐5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis
por: Han, Fushi, et al.
Publicado: (2022)

MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung
por: Hassan, Fatemat, et al.
Publicado: (2012)

miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5
por: Yuan, Chao, et al.
Publicado: (2021)

Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
por: Abdi, Jahangir, et al.
Publicado: (2019)

The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5
por: Yu, Xiaojie, et al.
Publicado: (2019)

Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation
por: Yan, Dan, et al.
Publicado: (2010)

Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma
por: Zhang, Kailiang, et al.
Publicado: (2020)

Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer
por: Dong, Xuetao, et al.
Publicado: (2018)

PTBP1 enhances miR-101-guided AGO2 targeting to MCL1 and promotes miR-101-induced apoptosis
por: Cui, Jia, et al.
Publicado: (2018)

The miR-4306/IGF2R axis modulates the lung adenocarcinoma response to irradiation in vitro and in vivo
por: Liu, Lipin, et al.
Publicado: (2021)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
por: Sun, Li, et al.
Publicado: (2021)

miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1
por: SUN, QUANQUAN, et al.
Publicado: (2015)

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
por: Wang, Baojin, et al.
Publicado: (2018)

LncRNA NEAT1-miR-101-3p/miR-335-5p/miR-374a-3p/miR-628-5p-TRIM6 axis identified as the prognostic biomarker for lung adenocarcinoma via bioinformatics and meta-analysis
por: Ding, Dong-Xiao, et al.
Publicado: (2021)

Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
por: Yao, Z.-S., et al.
Publicado: (2018)

miR‐92a‐3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis
por: Yu, Zhi‐Hao, et al.
Publicado: (2022)

Low-Temperature Plasma Suppresses Proliferation and Induces Apoptosis in Lung Cancer Cells by Regulating the miR-203a/BIRC5 Axis
por: Yang, Yang, et al.
Publicado: (2020)

Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a
por: Chi, Xiao-Jv, et al.
Publicado: (2021)

Effects of miR-101, miR-345 on HBV replication regulation and on the growth of liver cancer cells
por: Ding, Aikun, et al.
Publicado: (2019)

Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
por: Wang, Tongfei, et al.
Publicado: (2021)

ICP4-induced miR-101 attenuates HSV-1 replication
por: Wang, Xiangling, et al.
Publicado: (2016)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

Fe(3)O(4) magnetic nanoparticle-enhanced radiotherapy for lung adenocarcinoma via delivery of siBIRC5 and AS-ODN
por: Chen, Shuzhen, et al.
Publicado: (2021)

BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
por: Ma, Teng, et al.
Publicado: (2022)

miR-101 inhibits glioma cell invasion via the downregulation of COX-2
por: Ma, Chunyang, et al.
Publicado: (2016)

The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2
por: Lin, Haopeng, et al.
Publicado: (2019)

Investigating VEGF. miR-145-3p, and miR-101-3p Expression in Patients with Cholangiocarcinoma
por: Calastri, Maria Clara Jessica, et al.
Publicado: (2022)

MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem
por: Liu, Ning, et al.
Publicado: (2022)

miR-101-3p Contributes to α-Synuclein Aggregation in Neural Cells through the miR-101-3p/SKP1/PLK2 Pathway
por: Zhang, Min, et al.
Publicado: (2021)

Influence of miR-101 on proliferation of liver cancer cells through the MAPK/ERK signaling pathway
por: Meng, Xuan, et al.
Publicado: (2020)

CircDOCK1 suppresses cell apoptosis via inhibition of miR-196a-5p by targeting BIRC3 in OSCC
por: Wang, Liping, et al.
Publicado: (2018)

MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
por: Kim, Jeong Seon, et al.
Publicado: (2019)

MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis
por: Wang, Zhiguo, et al.
Publicado: (2018)

miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2020)

CircCAMSAP1 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis by sponging miR-1182 and regulating BIRC5
por: Wang, Yunfei, et al.
Publicado: (2022)

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
por: Alajez, N M, et al.
Publicado: (2010)

Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction
por: Maries, Liana, et al.
Publicado: (2023)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uhlts7p6u7fkgpsb4jdsoqsad6